Fetal Diagnosis and Therapy · 2019 · 26 citations · 34 references
MedicineMaternal HealthObstetricsHigh-risk PregnancyMaternal-fetal MedicineReproductive EndocrinologyEclampsiaHypertensive DisordersPregnancyPregnancy DiagnosisPrenatal AssessmentPrenatal Risk AssessmentB-type Natriuretic PeptidesBiomarkers Of PreeclampsiaEarly Detection Of PreeclampsiaNeutrophil Gelatinase-associated LipocalinPrediction ModelsPreeclampsia Risk AssessmentPreeclampsia Risk PredictionPreeclampsia Risk Screening
OBJECTIVE: To evaluate the performance of maternal risk factors (BMI and mean arterial pressure [MAP]) and first-trimester maternal serum markers in the early prediction of preeclampsia (PE) in nulliparous women. MATERIAL AND METHODS: This was a case-cohort study based on a cohort of 14,207 nulliparous women. A total of 213 cases with term PE (from 37 weeks + 0 days) and 55 cases with preterm PE (before 37 weeks + 0 days) were identified and validated. Randomly, 449 controls were selected. Serum samples previously collected for the double test (pregnancy-associated plasma protein A [PAPP-A] and free β human chorionic gonadotrophin [hCGβ]) as part of the first-trimester screening program were retrieved and analyzed for placental growth factor (PlGF), soluble fms-like tyrosine kinase 1 (sFlt-1), N-terminal pro-B-type natriuretic peptide (NT-proBNP), and neutrophil gelatinase-associated lipocalin (NGAL). Concentrations were transformed to multiples of the median (MoM). Multivariate regression analysis was used for prediction models. Receiver-operating characteristics (ROC) curves were used for evaluation of the screening performance. RESULTS: In preterm PE, the PlGF (0.79 MoM), sFlt-1 (0.86 MoM), NGAL (1.15 MoM), and PAPP-A (0.89 MoM) medians were significantly altered. In term PE, PlGF (0.90 MoM) and NT-proBNP (0.86 MoM) medians were significantly reduced. The combination of MAP and PlGF yielded a 39% detection rate of preterm PE for a 10% false-positive rate. The combination of MAP, BMI, and PlGF yielded a 33% detection rate of term PE with a 10% false-positive rate. CONCLUSION: First-trimester MAP, maternal serum PlGF, and NGAL are markers of preterm PE. Maternal serum sFlt-1 is a significant marker of preterm PE, but only early in the first trimester. First-trimester maternal serum NT-proBNP is not a predictor of PE. Screening performance for PE with these markers individually or in combination is modest.
34
Circulating Angiogenic Factors and the Risk of Preeclampsia
Richard J. Levine, Cong Qian, Lucinda J. England et al. · New England Journal of Medicine · 2004 · 3.6K citations · Full text
Circulating angiogenic factors and the risk of preeclampsia*
Obstetrics and Gynecology · 2004 · 2.6K citations
Medicine, Gynecology, Obstetrics +14
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Daniel L. Rolnik, D. Wright, Liona C. Poon et al. · New England Journal of Medicine · 2017 · 2.2K citations · Full text
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron
Trude Helen Flo, Kelly D. Smith, Shintaro Sato et al. · Nature · 2004 · 1.9K citations
Intrauterine growth curves based on ultrasonically estimated foetal weights
K. Maršál, P‐H. Persson, Torben Larsen et al. · Acta Paediatrica · 1996 · 1.9K citations